Requirement for LYT-2/3 Molecules on Allospecific Cytolytic T Lymphocyte Clones is Dependent Upon Target Cell Antigen Density

  • Richard Shimonkevitz
  • Jean-Charles Cerottini
  • H. Robson MacDonald
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 187)


The Lyt-2/3 antigenic complex in the mouse (1) is expressed preferentially on cytolytic T lymphocytes (CTL) and appears to be involved in the recognition of target cells (2,3). In the course of investigating this phenomenon at the clonal level, we observed that individual CTL clones vary greatly in their requirement for Lyt-2/3 molecules in killing. Thus some CTL clones lose cytolytic activity when treated with monoclonal antibodies (MAbs) directed against Lyt-2/3 (4) or with doses of trypsin which selectively cleave the Lyt-2/3 antigenic determinant from the cell surface (5), whereas other clones are resistant to either treatment. Based on these findings, we (6) and others (7,8) have postulated that the role of the Lyt-2/3 molecules may be to facilitate and/or stabilize the interaction between CTL and their target cells. According to this model, the degree to which Lyt-2/3 molecules are required for effective CTL-target cell binding would be inversely related to the intrinsic affinity of the CTL antigen receptor (6).


Target Cell Antigenic Determinant Cytolytic Activity Clonal Heterogeneity Clonal Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    E.A. Boyse, M. Miyazawa, T. Aoki, and L.J. Old, Ly-A and Ly-B: two systems of lymphocyte isoantigens in the mouse, Proc. R. Soc. Lond. (Biol.) 170:175 (1968).CrossRefGoogle Scholar
  2. 2.
    E. Nakayama, H. Shiku, E. Stockert, H.F. Oettgen, and L.J. Old, Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera, Proc. natl. Acad. Sci 76:1977 (1979).Google Scholar
  3. 3.
    N. Shinohara, and D.H. Sachs, Mouse alloantibodies capable of blocking cytotoxic T-cell function. I. Relationship between the antigen reactive with blocking antibodies and the Lyt-2 locus, J. exp. Med. 150:432 (1979).PubMedCrossRefGoogle Scholar
  4. 4.
    H.R. MacDonald, N. Thiernesse, and J.-C. Cerottini, Inhibition of T cell-mediated cytolysis by monoclonal antibodies directed against Lyt-2: heterogeneity of inhibition at the clonal level, J. Immunol. 126:1671 (1981).PubMedGoogle Scholar
  5. 5.
    H.R. MacDonald, A.L. Glasebrook, and J.-C. Cerottini, Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes: analysis by antibody blocking and selective trypsinization, J. exp. Med. 156:1711 (1982).PubMedCrossRefGoogle Scholar
  6. 6.
    H.R. MacDonald, A.L. Glasebrook, C. Bron, A. Kelso, and J.-C. Cerottini, Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes (CTL): Possible implications for the affinity of CTL antigen receptors, Immunol. Rev. 68:89 (1982).PubMedCrossRefGoogle Scholar
  7. 7.
    E. Martz, W. Heagy, and S.H. Gromkowski, The mechanism of CTL-mediated killing: monoclonal antibody analysis of the roles of killer and target cell membrane proteins, Immunol. Rev. 72:73 (1983).PubMedCrossRefGoogle Scholar
  8. 8.
    S.L. Swain, T cell subsets and the recognition of MHC class, Immunol. Rev. 74:129 (1983).PubMedCrossRefGoogle Scholar
  9. 9.
    H.R. MacDonald, J.-C. Cerottini, J.-E. Ryser, J.L. Maryanski, C. Taswell, M.B. Widmer, and K.T. Brunner, Quantitation and cloning of cytolytic T lymphocytes and their precursors, Immunol. Rev. 51:93 (1980).PubMedCrossRefGoogle Scholar
  10. 10.
    J.-C. Cerottini, H.D. Engers, H.R. MacDonald, and K.T. Brunner, Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte culture, J. exp. Med. 140:703 (1974).PubMedCrossRefGoogle Scholar
  11. 11.
    B. Arnold, H.-G. Burgert, U. Hamann, G. Hammerling, U. Kees, and S. Kvist, Cytolytic T cells recognize the two amino-terminal domains of H-2K antigens in tandem in influenza A infected cells, Cell 38:79 (1984).PubMedCrossRefGoogle Scholar
  12. 12.
    D. Kemp, A. Harris, S. Cory, and J. Adams, Expression of the immunoglobulin Cu gene in mouse T and B lymphoid and myeloid cell lines, Proc. natl. Acad. Sci 77:2876 (1980).PubMedCrossRefGoogle Scholar
  13. 13.
    D. Wallach, M. Fellows, and M. Revel, Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells, Nature 299:833 (1982).PubMedCrossRefGoogle Scholar
  14. 14.
    S.H. Gromkowski, W.E. Heagy, F. Sanchez-Madrid, T.A. Springer, and E. Martz, Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2/3. I. Increased susceptibility to blocking after papain treatment of target cells, J. Immunol. 130:2546 (1983).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Richard Shimonkevitz
    • 1
  • Jean-Charles Cerottini
    • 1
  • H. Robson MacDonald
    • 1
  1. 1.Lausanne BranchLudwig Institute for Cancer ResearchEpalingesSwitzerland

Personalised recommendations